Short Interest in Hypera S.A. (OTCMKTS:HYPMY) Rises By 28.4%

Hypera S.A. (OTCMKTS:HYPMY) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 14,900 shares, an increase of 28.4% from the November 30th total of 11,600 shares. Based on an average trading volume of 50,400 shares, the days-to-cover ratio is currently 0.3 days.

Hypera Stock Down 1.0 %

HYPMY stock opened at $2.88 on Friday. The company has a market cap of $1.83 billion, a price-to-earnings ratio of 5.44 and a beta of 1.02. Hypera has a 12-month low of $2.64 and a 12-month high of $7.65. The company has a 50 day moving average of $3.51 and a two-hundred day moving average of $4.60.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.